GSK Hits Apotex With Suit Over Bid For Generic Prostate Drug
GlaxoSmithKline PLC hit generic drugmaker Apotex Inc. with a lawsuit Thursday, claiming the company's planned generic version of prostate drug Avodart would infringe one of GSK's patents....To view the full article, register now.
Already a subscriber? Click here to view full article